FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts.

Published

Journal Article

BACKGROUND: Transplant tolerance, rather than immunity, may be favored in the setting of a lower mature lymphoid mass in the recipient induced by anti-T cell agents. A novel immunosuppressive agent, FN18-CRM9, known to specifically kill T cells with great potency, was evaluated in a transplant model. METHODS: In order to ablate recipient T cells, the immunotoxin FN18-CRM9 was administered to rhesus monkey recipients of MHC-mismatched renal allografts. Donor lymphocytes were injected intrathymically into some animals. RESULTS: All monkeys with T-cell depletion by immunotoxin had prolonged allograft survival, and tolerance confirmed by skin grafting has been confirmed in five of six long-surviving recipients. CONCLUSIONS: In this clinically relevant model, profound but transient T-cell depletion by a single agent substantially promotes tolerance.

Full Text

Duke Authors

Cited Authors

  • Knechtle, SJ; Vargo, D; Fechner, J; Zhai, Y; Wang, J; Hanaway, MJ; Scharff, J; Hu, H; Knapp, L; Watkins, D; Neville, DM

Published Date

  • January 15, 1997

Published In

Volume / Issue

  • 63 / 1

Start / End Page

  • 1 - 6

PubMed ID

  • 9000652

Pubmed Central ID

  • 9000652

International Standard Serial Number (ISSN)

  • 0041-1337

Digital Object Identifier (DOI)

  • 10.1097/00007890-199701150-00002

Language

  • eng

Conference Location

  • United States